Clinical Reasoning in Practice: Implementing High-Value Care When Data Discrepancies Arise

• by Rohan Rao, Katya Lavine, Anand A. Patel, Christopher Moriates

• April 20, 2026

Biochemical Tumor Markers: Are New Testing Guidelines Fit for Purpose?

CLSI guidance achieves technical excellence but has some questionable omissions, says Mustafa Barbhuiya

• by Mustafa Barbhuiya

• March 18, 2026

• 4 min

Understanding the Role of Regulatory T Cells in the Immune Microenvironment of Multiple Myeloma and Its Clinical Implications

• by Lijun Du, Yumeng Jiang, Qiaolin Zhou, Fang Xu

• April 29, 2026

Enterocolitis Associated with Immune Effector Cells Following BCMA-Targeted CAR T-Cell Therapy: Findings from a Multicenter Case Series

• by Sandra Susanibar-Adaniya, Benjamin A. Derman, Adam D. Cohen, Dan T. Vogl, Shambavi Richard, Adriana Rossi, Matthew J. Frigualt, Andrew J. Yee, Binod Dhakal, Noffar Bar

• April 28, 2026